

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54769417 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.54769417 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.29374315 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.29374315 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.95285677 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64494255 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.42025762 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.42025762 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.42025762 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.24574909 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17124106 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.12385255 |
| 13 | urea metabolic process (GO:0019627) | 5.11513858 |
| 14 | urea cycle (GO:0000050) | 5.11513858 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.06722224 |
| 16 | * sulfur amino acid catabolic process (GO:0000098) | 5.00187985 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.98075480 |
| 18 | cysteine metabolic process (GO:0006534) | 4.94305329 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93234858 |
| 20 | protein carboxylation (GO:0018214) | 4.93234858 |
| 21 | complement activation, alternative pathway (GO:0006957) | 4.92728091 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85229429 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.82286673 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.72237740 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.67752396 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.67636343 |
| 27 | bile acid metabolic process (GO:0008206) | 4.57044573 |
| 28 | homocysteine metabolic process (GO:0050667) | 4.56601161 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.55988276 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.51646621 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.43720537 |
| 32 | regulation of complement activation (GO:0030449) | 4.41618559 |
| 33 | bile acid and bile salt transport (GO:0015721) | 4.41040700 |
| 34 | lysine metabolic process (GO:0006553) | 4.39012811 |
| 35 | lysine catabolic process (GO:0006554) | 4.39012811 |
| 36 | response to peptidoglycan (GO:0032494) | 4.36116748 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.32906731 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.32163180 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.29895050 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.28798919 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.27613448 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.27564784 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.26848925 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.26848925 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.26848925 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.23552103 |
| 47 | phospholipid efflux (GO:0033700) | 4.20213477 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.16288859 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.16288859 |
| 50 | cellular glucuronidation (GO:0052695) | 4.11682965 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.11658877 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.08716973 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.04992934 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.04992934 |
| 55 | ethanol oxidation (GO:0006069) | 4.04274159 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.03428863 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.95389098 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 3.90410882 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83941818 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.83801732 |
| 61 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77133524 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.75498852 |
| 63 | * cellular amino acid catabolic process (GO:0009063) | 3.74924446 |
| 64 | benzene-containing compound metabolic process (GO:0042537) | 3.74835686 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.74390731 |
| 66 | cholesterol efflux (GO:0033344) | 3.74187677 |
| 67 | drug catabolic process (GO:0042737) | 3.73961727 |
| 68 | amine catabolic process (GO:0009310) | 3.73602940 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.73602940 |
| 70 | uronic acid metabolic process (GO:0006063) | 3.72623639 |
| 71 | glucuronate metabolic process (GO:0019585) | 3.72623639 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.71934058 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.71934058 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.69130507 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.68974911 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.68909012 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.68819614 |
| 78 | ketone body metabolic process (GO:1902224) | 3.67343968 |
| 79 | response to type I interferon (GO:0034340) | 3.66279884 |
| 80 | regulation of vitamin metabolic process (GO:0030656) | 3.65755526 |
| 81 | aldehyde catabolic process (GO:0046185) | 3.65407629 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.64804802 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 3.63696266 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 3.61481851 |
| 85 | fatty acid beta-oxidation (GO:0006635) | 3.58990556 |
| 86 | fatty acid oxidation (GO:0019395) | 3.58050365 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.57952329 |
| 88 | fibrinolysis (GO:0042730) | 3.54044620 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 3.52977361 |
| 90 | lipid oxidation (GO:0034440) | 3.52720489 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 3.51560261 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51416029 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51416029 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.50779979 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.49836249 |
| 96 | glutamate metabolic process (GO:0006536) | 3.49517515 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 3.47661827 |
| 98 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47071494 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 3.47071494 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47071494 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47071494 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47071494 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 3.47071494 |
| 104 | negative regulation of cell killing (GO:0031342) | 3.46620931 |
| 105 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46620931 |
| 106 | drug transmembrane transport (GO:0006855) | 3.46392897 |
| 107 | cofactor catabolic process (GO:0051187) | 3.46189716 |
| 108 | * carboxylic acid catabolic process (GO:0046395) | 3.45810114 |
| 109 | * organic acid catabolic process (GO:0016054) | 3.45810114 |
| 110 | sterol homeostasis (GO:0055092) | 3.45337098 |
| 111 | serine family amino acid metabolic process (GO:0009069) | 3.44462318 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 3.43894813 |
| 113 | glycine metabolic process (GO:0006544) | 3.43070458 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.42600747 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42386794 |
| 116 | arginine metabolic process (GO:0006525) | 3.41274360 |
| 117 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40398541 |
| 118 | carnitine metabolic process (GO:0009437) | 3.40139813 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.38915613 |
| 120 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37697468 |
| 121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36854552 |
| 122 | plasma lipoprotein particle organization (GO:0071827) | 3.36668629 |
| 123 | regulation of podosome assembly (GO:0071801) | 3.35835840 |
| 124 | complement activation (GO:0006956) | 3.34224872 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.33554321 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32858224 |
| 127 | protein activation cascade (GO:0072376) | 3.31856767 |
| 128 | T-helper 1 type immune response (GO:0042088) | 3.27892986 |
| 129 | detection of other organism (GO:0098543) | 3.27690335 |
| 130 | myeloid dendritic cell differentiation (GO:0043011) | 3.26372218 |
| 131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23505831 |
| 132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23152672 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22043889 |
| 134 | glycosphingolipid catabolic process (GO:0046479) | 3.20038497 |
| 135 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.18015988 |
| 136 | detection of bacterium (GO:0016045) | 3.10868641 |
| 137 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10661693 |
| 138 | regulation of interferon-alpha production (GO:0032647) | 3.09641230 |
| 139 | granulocyte activation (GO:0036230) | 3.07212330 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06898108 |
| 141 | positive regulation of type 2 immune response (GO:0002830) | 3.05791106 |
| 142 | germinal center formation (GO:0002467) | 3.01426009 |
| 143 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00487069 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.98055296 |
| 145 | defense response to protozoan (GO:0042832) | 2.97344374 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.97151182 |
| 147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96643333 |
| 148 | B cell mediated immunity (GO:0019724) | 2.96482722 |
| 149 | response to protozoan (GO:0001562) | 2.96284032 |
| 150 | regulation of chronic inflammatory response (GO:0002676) | 2.96086155 |
| 151 | detection of molecule of bacterial origin (GO:0032490) | 2.94950170 |
| 152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.94945022 |
| 153 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.93841469 |
| 154 | glycolipid catabolic process (GO:0019377) | 2.92928978 |
| 155 | myeloid dendritic cell activation (GO:0001773) | 2.92807970 |
| 156 | regulation of chemokine biosynthetic process (GO:0045073) | 2.91910800 |
| 157 | oligosaccharide catabolic process (GO:0009313) | 2.91813829 |
| 158 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89057537 |
| 159 | detection of external biotic stimulus (GO:0098581) | 2.89057271 |
| 160 | eosinophil chemotaxis (GO:0048245) | 2.89029968 |
| 161 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87758507 |
| 162 | cellular response to interferon-gamma (GO:0071346) | 2.86823612 |
| 163 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.85516327 |
| 164 | monocyte chemotaxis (GO:0002548) | 2.84263321 |
| 165 | positive regulation of interferon-alpha production (GO:0032727) | 2.79411212 |
| 166 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78375648 |
| 167 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.77710581 |
| 168 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.77300847 |
| 169 | response to interferon-gamma (GO:0034341) | 2.76403628 |
| 170 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.75573614 |
| 171 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.73221403 |
| 172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72866476 |
| 173 | lymphocyte chemotaxis (GO:0048247) | 2.71925934 |
| 174 | myeloid cell activation involved in immune response (GO:0002275) | 2.71107211 |
| 175 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.71080643 |
| 176 | dendritic cell differentiation (GO:0097028) | 2.70601388 |
| 177 | neutrophil activation (GO:0042119) | 2.70343810 |
| 178 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.69792251 |
| 179 | regulation of interleukin-12 production (GO:0032655) | 2.68778041 |
| 180 | regulation of tolerance induction (GO:0002643) | 2.68678261 |
| 181 | cellular extravasation (GO:0045123) | 2.68412691 |
| 182 | regulation of type 2 immune response (GO:0002828) | 2.67490480 |
| 183 | regulation of macrophage chemotaxis (GO:0010758) | 2.63750593 |
| 184 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63240434 |
| 185 | response to muramyl dipeptide (GO:0032495) | 2.62330549 |
| 186 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60621582 |
| 187 | macrophage activation (GO:0042116) | 2.58686748 |
| 188 | cellular response to lipopolysaccharide (GO:0071222) | 2.58481410 |
| 189 | leukocyte aggregation (GO:0070486) | 2.57963997 |
| 190 | eosinophil migration (GO:0072677) | 2.57213733 |
| 191 | respiratory burst (GO:0045730) | 2.55216148 |
| 192 | T cell migration (GO:0072678) | 2.55053742 |
| 193 | cellular response to molecule of bacterial origin (GO:0071219) | 2.53690357 |
| 194 | ceramide catabolic process (GO:0046514) | 2.53599640 |
| 195 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.53576835 |
| 196 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.52876407 |
| 197 | detection of biotic stimulus (GO:0009595) | 2.52492354 |
| 198 | positive regulation of heat generation (GO:0031652) | 2.52104764 |
| 199 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50913983 |
| 200 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.48934168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.24812181 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.32804429 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.02020837 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.80798301 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.06605978 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.65806904 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.35368434 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.33643954 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31107676 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82908356 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79790522 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74737287 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70455867 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.56916281 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50887290 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43937100 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35079347 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03584155 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02698287 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00994649 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0695145 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96687471 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95534976 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95313873 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91236202 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87749861 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84163266 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81255261 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79575560 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77565542 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68930660 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66877490 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64916377 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60357899 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59994543 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59592738 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.58547920 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.53239020 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50676450 |
| 40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48301719 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46972164 |
| 42 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42605074 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40763338 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39277985 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37630222 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35937866 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35248570 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35108522 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32560253 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32295198 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27800584 |
| 52 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27784737 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24858871 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24681264 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24543176 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23778607 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23107518 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22551398 |
| 59 | * MYB_26560356_Chip-Seq_TH1_Human | 1.22471253 |
| 60 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20962653 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20554867 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19238702 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17020056 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16765366 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15267089 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12973145 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12093176 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11666398 |
| 69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11259318 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10886639 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10614432 |
| 72 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08589652 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04950683 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04306846 |
| 75 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03637386 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03119396 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02863759 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99407827 |
| 79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99237978 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98703213 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98330903 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97483441 |
| 83 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97294612 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96919220 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95089697 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94959951 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94368403 |
| 88 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93755220 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93143425 |
| 90 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93044148 |
| 91 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93044148 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92273209 |
| 93 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91880200 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91632331 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91099748 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90724099 |
| 97 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90598681 |
| 98 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88874885 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88767776 |
| 100 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87707565 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84540190 |
| 102 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84034344 |
| 103 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84034344 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81748482 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81035718 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80548888 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80483854 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80461616 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79133463 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76657026 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75799054 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75658627 |
| 113 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74625828 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74625115 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72892589 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72631562 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72313694 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70707107 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69475474 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.69390546 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68916510 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68848101 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68728692 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67926224 |
| 125 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67701446 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67029995 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66843449 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66581008 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65771634 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65489414 |
| 131 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.65060362 |
| 132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64843873 |
| 133 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.64597931 |
| 134 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64120565 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63266821 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62976851 |
| 137 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61831189 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.61740778 |
| 139 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61582101 |
| 140 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60767304 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.60270076 |
| 142 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.59740769 |
| 143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59393374 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59318130 |
| 145 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59119175 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.59056521 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57939241 |
| 148 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57902520 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57427157 |
| 150 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57227582 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.56537443 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.55154965 |
| 153 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.54803803 |
| 154 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.54634015 |
| 155 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54534876 |
| 156 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.53247060 |
| 157 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52605942 |
| 158 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.52329971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.29834158 |
| 2 | MP0005360_urolithiasis | 6.76344272 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.66851365 |
| 4 | MP0005365_abnormal_bile_salt | 5.52259684 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.77352710 |
| 6 | MP0003303_peritoneal_inflammation | 4.17679842 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.85283681 |
| 8 | MP0003252_abnormal_bile_duct | 3.55350924 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.28531667 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.14372566 |
| 11 | MP0009840_abnormal_foam_cell | 3.00227996 |
| 12 | MP0003195_calcinosis | 2.66576343 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65911054 |
| 14 | MP0005387_immune_system_phenotype | 2.65247080 |
| 15 | MP0001790_abnormal_immune_system | 2.65247080 |
| 16 | MP0005083_abnormal_biliary_tract | 2.62081572 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.61363398 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.60506739 |
| 19 | MP0005671_abnormal_response_to | 2.60011980 |
| 20 | MP0005332_abnormal_amino_acid | 2.56701036 |
| 21 | MP0000685_abnormal_immune_system | 2.18170143 |
| 22 | MP0004510_myositis | 2.17552108 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.13605578 |
| 24 | MP0001800_abnormal_humoral_immune | 2.13459335 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.13173750 |
| 26 | MP0002723_abnormal_immune_serum | 2.09693728 |
| 27 | MP0000609_abnormal_liver_physiology | 2.07532631 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 2.04348727 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 2.00235560 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.86598537 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.84577330 |
| 32 | MP0001819_abnormal_immune_cell | 1.82054925 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.81991751 |
| 34 | MP0003868_abnormal_feces_composition | 1.73276482 |
| 35 | MP0002405_respiratory_system_inflammati | 1.62921194 |
| 36 | MP0001764_abnormal_homeostasis | 1.62257214 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.59205342 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57505203 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.52785252 |
| 40 | MP0009278_abnormal_bone_marrow | 1.51756100 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.51308533 |
| 42 | MP0003186_abnormal_redox_activity | 1.49864111 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.48810696 |
| 44 | MP0005670_abnormal_white_adipose | 1.47448530 |
| 45 | MP0000858_altered_metastatic_potential | 1.46210138 |
| 46 | MP0003448_altered_tumor_morphology | 1.45362212 |
| 47 | MP0006054_spinal_hemorrhage | 1.42823105 |
| 48 | MP0005310_abnormal_salivary_gland | 1.42502936 |
| 49 | MP0008004_abnormal_stomach_pH | 1.36469777 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.32536018 |
| 51 | MP0009764_decreased_sensitivity_to | 1.30782124 |
| 52 | MP0000716_abnormal_immune_system | 1.27895528 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.27556024 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.27556024 |
| 55 | MP0003724_increased_susceptibility_to | 1.24246374 |
| 56 | MP0009697_abnormal_copulation | 1.23717696 |
| 57 | MP0005451_abnormal_body_composition | 1.23624713 |
| 58 | MP0008260_abnormal_autophagy | 1.20818535 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.19421935 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.19417432 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.17148551 |
| 62 | MP0008469_abnormal_protein_level | 1.12945965 |
| 63 | MP0000598_abnormal_liver_morphology | 1.10284806 |
| 64 | MP0002398_abnormal_bone_marrow | 1.08796666 |
| 65 | MP0004130_abnormal_muscle_cell | 1.08304139 |
| 66 | MP0003436_decreased_susceptibility_to | 1.06221687 |
| 67 | MP0000604_amyloidosis | 1.06161091 |
| 68 | MP0009763_increased_sensitivity_to | 1.05145037 |
| 69 | MP0003011_delayed_dark_adaptation | 1.04723937 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.04517662 |
| 71 | MP0001873_stomach_inflammation | 1.03844915 |
| 72 | MP0005647_abnormal_sex_gland | 0.99705577 |
| 73 | MP0002429_abnormal_blood_cell | 0.97872086 |
| 74 | MP0003866_abnormal_defecation | 0.97731572 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.97591169 |
| 76 | MP0002254_reproductive_system_inflammat | 0.96922180 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.96321220 |
| 78 | MP0005165_increased_susceptibility_to | 0.95691186 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.95423421 |
| 80 | MP0005023_abnormal_wound_healing | 0.95305629 |
| 81 | MP0003828_pulmonary_edema | 0.95244011 |
| 82 | MP0003091_abnormal_cell_migration | 0.93481264 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.92044965 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.91569099 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.90964816 |
| 86 | MP0005390_skeleton_phenotype | 0.88674715 |
| 87 | MP0002971_abnormal_brown_adipose | 0.88273175 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.87519392 |
| 89 | MP0002722_abnormal_immune_system | 0.87402059 |
| 90 | MP0005410_abnormal_fertilization | 0.85493059 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.85039626 |
| 92 | MP0009785_altered_susceptibility_to | 0.83233175 |
| 93 | MP0005334_abnormal_fat_pad | 0.82518186 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.82490213 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.81705112 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.81532072 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.81149749 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.80595817 |
| 99 | MP0001756_abnormal_urination | 0.80505535 |
| 100 | MP0001542_abnormal_bone_strength | 0.80097781 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.80021827 |
| 102 | MP0002933_joint_inflammation | 0.79529986 |
| 103 | MP0006082_CNS_inflammation | 0.78032417 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.77165206 |
| 105 | MP0003075_altered_response_to | 0.75681327 |
| 106 | MP0003795_abnormal_bone_structure | 0.75312845 |
| 107 | MP0003690_abnormal_glial_cell | 0.74639374 |
| 108 | MP0005408_hypopigmentation | 0.74559750 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.73764544 |
| 110 | MP0001851_eye_inflammation | 0.73501836 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.73086365 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.72991212 |
| 113 | MP0000490_abnormal_crypts_of | 0.71305622 |
| 114 | MP0005535_abnormal_body_temperature | 0.71140101 |
| 115 | MP0005166_decreased_susceptibility_to | 0.70090688 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.68646654 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.68331950 |
| 118 | MP0008874_decreased_physiological_sensi | 0.68310253 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.67607263 |
| 120 | MP0003045_fibrosis | 0.67065755 |
| 121 | MP0005220_abnormal_exocrine_pancreas | 0.66729496 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.66165834 |
| 123 | MP0000920_abnormal_myelination | 0.65819343 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.65406422 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.64402442 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.64379367 |
| 127 | MP0004043_abnormal_pH_regulation | 0.63440643 |
| 128 | MP0002419_abnormal_innate_immunity | 0.63012659 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.62534306 |
| 130 | MP0002006_tumorigenesis | 0.62066634 |
| 131 | MP0001853_heart_inflammation | 0.61949002 |
| 132 | MP0005448_abnormal_energy_balance | 0.61632623 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.61548635 |
| 134 | MP0005025_abnormal_response_to | 0.61279188 |
| 135 | MP0001661_extended_life_span | 0.60218453 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.59108040 |
| 137 | MP0005266_abnormal_metabolism | 0.59102468 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.58457575 |
| 139 | MP0009115_abnormal_fat_cell | 0.56496066 |
| 140 | MP0001533_abnormal_skeleton_physiology | 0.56013977 |
| 141 | MP0000249_abnormal_blood_vessel | 0.55537580 |
| 142 | MP0005164_abnormal_response_to | 0.53539683 |
| 143 | MP0008873_increased_physiological_sensi | 0.50697085 |
| 144 | MP0004947_skin_inflammation | 0.50353710 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.47908469 |
| 146 | MP0002928_abnormal_bile_duct | 0.47319881 |
| 147 | MP0001663_abnormal_digestive_system | 0.46710005 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.46032569 |
| 149 | MP0001835_abnormal_antigen_presentation | 0.45816829 |
| 150 | MP0002060_abnormal_skin_morphology | 0.45557389 |
| 151 | MP0003953_abnormal_hormone_level | 0.45042163 |
| 152 | MP0004883_abnormal_blood_vessel | 0.44582945 |
| 153 | MP0002132_abnormal_respiratory_system | 0.44443612 |
| 154 | MP0000343_altered_response_to | 0.42440673 |
| 155 | MP0003329_amyloid_beta_deposits | 0.42047877 |
| 156 | MP0002168_other_aberrant_phenotype | 0.40162333 |
| 157 | MP0006035_abnormal_mitochondrial_morpho | 0.39603353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.45058442 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.41163696 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.25220673 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.97242571 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.97242571 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.97242571 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.90670909 |
| 8 | Xanthomatosis (HP:0000991) | 5.68756308 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.62194019 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.35964794 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.98446904 |
| 12 | Complement deficiency (HP:0004431) | 4.95560082 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.84116918 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.75930066 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.57293360 |
| 16 | Joint hemorrhage (HP:0005261) | 4.37083372 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.35823219 |
| 18 | Hyperammonemia (HP:0001987) | 4.32900916 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.26376596 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 4.24713119 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13143168 |
| 22 | Ketosis (HP:0001946) | 4.11532633 |
| 23 | Hypoglycemic coma (HP:0001325) | 4.11465410 |
| 24 | Orchitis (HP:0100796) | 4.09912962 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08084174 |
| 26 | Myositis (HP:0100614) | 4.04051365 |
| 27 | Epidermoid cyst (HP:0200040) | 3.99666986 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95761405 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.92089231 |
| 30 | Hyperglycinemia (HP:0002154) | 3.89800027 |
| 31 | Optic neuritis (HP:0100653) | 3.86992316 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.86992316 |
| 33 | Fat malabsorption (HP:0002630) | 3.84926604 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.76567415 |
| 35 | Abnormality of complement system (HP:0005339) | 3.75521307 |
| 36 | Hyperglycinuria (HP:0003108) | 3.74343338 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 3.72014793 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68947461 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.64294515 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64294515 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61868944 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.60709039 |
| 43 | Loss of speech (HP:0002371) | 3.60394346 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57161558 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55811429 |
| 46 | Stomatitis (HP:0010280) | 3.52286058 |
| 47 | Hypercholesterolemia (HP:0003124) | 3.42478764 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 3.40197589 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.38617181 |
| 50 | Disinhibition (HP:0000734) | 3.32358160 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 3.28420997 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27487185 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 3.23135377 |
| 54 | Ketoacidosis (HP:0001993) | 3.13513169 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.10029374 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07860192 |
| 57 | Hyperbilirubinemia (HP:0002904) | 3.04521686 |
| 58 | Myocardial infarction (HP:0001658) | 3.02838189 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02521763 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01371767 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00826193 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.97042964 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.95268124 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.95268124 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.95268124 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.86277862 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86277862 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.86149814 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86149814 |
| 70 | Steatorrhea (HP:0002570) | 2.85604673 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.82168184 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.78636339 |
| 73 | Vascular calcification (HP:0004934) | 2.77547931 |
| 74 | Metabolic acidosis (HP:0001942) | 2.77181067 |
| 75 | Obstructive lung disease (HP:0006536) | 2.74308992 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74308992 |
| 77 | Recurrent skin infections (HP:0001581) | 2.71359837 |
| 78 | Vasculitis (HP:0002633) | 2.68535449 |
| 79 | Glomerulonephritis (HP:0000099) | 2.68497666 |
| 80 | Hepatocellular carcinoma (HP:0001402) | 2.64925546 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.62864918 |
| 82 | Increased serum ferritin (HP:0003281) | 2.62862978 |
| 83 | Increased IgM level (HP:0003496) | 2.61979754 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.61629710 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.61558450 |
| 86 | Skin nodule (HP:0200036) | 2.60661945 |
| 87 | Neurofibrillary tangles (HP:0002185) | 2.59148917 |
| 88 | Gingivitis (HP:0000230) | 2.57692201 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.55312282 |
| 90 | Petechiae (HP:0000967) | 2.55021663 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.54675761 |
| 92 | Gout (HP:0001997) | 2.54596778 |
| 93 | Spontaneous abortion (HP:0005268) | 2.53646910 |
| 94 | Mutism (HP:0002300) | 2.53386808 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.52057967 |
| 96 | Hemoptysis (HP:0002105) | 2.51896148 |
| 97 | Nuclear cataract (HP:0100018) | 2.51314415 |
| 98 | Lethargy (HP:0001254) | 2.51110310 |
| 99 | T lymphocytopenia (HP:0005403) | 2.50704462 |
| 100 | Delayed CNS myelination (HP:0002188) | 2.49697707 |
| 101 | Purpura (HP:0000979) | 2.48294637 |
| 102 | Malnutrition (HP:0004395) | 2.47758057 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.43906761 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 2.43780600 |
| 105 | Esophageal varix (HP:0002040) | 2.42954271 |
| 106 | Urticaria (HP:0001025) | 2.42256167 |
| 107 | Pancreatitis (HP:0001733) | 2.41528032 |
| 108 | Abnormality of T cell number (HP:0011839) | 2.41042857 |
| 109 | Meningitis (HP:0001287) | 2.39233317 |
| 110 | Recurrent viral infections (HP:0004429) | 2.35228539 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.34544529 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 2.33511719 |
| 113 | Hematochezia (HP:0002573) | 2.31995227 |
| 114 | Cerebral edema (HP:0002181) | 2.28238228 |
| 115 | Gangrene (HP:0100758) | 2.27334330 |
| 116 | Acanthocytosis (HP:0001927) | 2.25197353 |
| 117 | Increased IgE level (HP:0003212) | 2.24978514 |
| 118 | Spontaneous hematomas (HP:0007420) | 2.24889495 |
| 119 | Hemorrhage of the eye (HP:0011885) | 2.24490187 |
| 120 | Late onset (HP:0003584) | 2.23746288 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 2.22739823 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 2.22629615 |
| 123 | Amyloidosis (HP:0011034) | 2.20831233 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.20590015 |
| 125 | Hydroxyprolinuria (HP:0003080) | 2.20590015 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19493708 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.19418487 |
| 128 | Gingival bleeding (HP:0000225) | 2.17242604 |
| 129 | Vomiting (HP:0002013) | 2.16023407 |
| 130 | Cholecystitis (HP:0001082) | 2.14615831 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 2.14615831 |
| 132 | Irritability (HP:0000737) | 2.14491301 |
| 133 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13915867 |
| 134 | Menorrhagia (HP:0000132) | 2.12217874 |
| 135 | Encephalitis (HP:0002383) | 2.11403700 |
| 136 | Abnormal gallbladder morphology (HP:0012437) | 2.11014701 |
| 137 | Spastic diplegia (HP:0001264) | 2.08578379 |
| 138 | Alkalosis (HP:0001948) | 2.07924150 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 2.07648345 |
| 140 | Proximal tubulopathy (HP:0000114) | 2.07127167 |
| 141 | Nephritis (HP:0000123) | 2.05874991 |
| 142 | Pustule (HP:0200039) | 2.05581632 |
| 143 | Polyneuropathy (HP:0001271) | 2.04328435 |
| 144 | Cholelithiasis (HP:0001081) | 2.04262757 |
| 145 | Mitral stenosis (HP:0001718) | 2.04243344 |
| 146 | Apathy (HP:0000741) | 2.02404344 |
| 147 | Abnormal cartilage morphology (HP:0002763) | 2.00857523 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 2.00652989 |
| 149 | Renal cortical cysts (HP:0000803) | 2.00426556 |
| 150 | Diminished motivation (HP:0000745) | 1.99661869 |
| 151 | Nausea (HP:0002018) | 1.99385304 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98714909 |
| 153 | Basal ganglia calcification (HP:0002135) | 1.98236320 |
| 154 | Asymmetric septal hypertrophy (HP:0001670) | 1.97736392 |
| 155 | Premature loss of primary teeth (HP:0006323) | 1.96677059 |
| 156 | Arterial thrombosis (HP:0004420) | 1.95859685 |
| 157 | Thrombophlebitis (HP:0004418) | 1.95823077 |
| 158 | Increased purine levels (HP:0004368) | 1.93490995 |
| 159 | Hyperuricemia (HP:0002149) | 1.93490995 |
| 160 | Metaphyseal irregularity (HP:0003025) | 1.92422968 |
| 161 | Leukocytosis (HP:0001974) | 1.91640103 |
| 162 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91201232 |
| 163 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91201232 |
| 164 | Symptomatic seizures (HP:0011145) | 1.91158000 |
| 165 | Anorexia (HP:0002039) | 1.89956640 |
| 166 | Cerebral inclusion bodies (HP:0100314) | 1.88965686 |
| 167 | Joint swelling (HP:0001386) | 1.88886219 |
| 168 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87459084 |
| 169 | Enlarged kidneys (HP:0000105) | 1.87016633 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.86748530 |
| 171 | Bone pain (HP:0002653) | 1.86729272 |
| 172 | Cellulitis (HP:0100658) | 1.86649667 |
| 173 | Abnormality of the nasal mucosa (HP:0000433) | 1.86001468 |
| 174 | Pulmonary embolism (HP:0002204) | 1.85415567 |
| 175 | Chronic diarrhea (HP:0002028) | 1.85099944 |
| 176 | Neonatal onset (HP:0003623) | 1.84541077 |
| 177 | Hypochromic microcytic anemia (HP:0004840) | 1.84039891 |
| 178 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82722738 |
| 179 | Axonal loss (HP:0003447) | 1.82382887 |
| 180 | Glomerulopathy (HP:0100820) | 1.82036116 |
| 181 | Abnormality of the pleura (HP:0002103) | 1.81925696 |
| 182 | Elevated hepatic transaminases (HP:0002910) | 1.81557652 |
| 183 | Glycosuria (HP:0003076) | 1.81470558 |
| 184 | Abnormality of urine glucose concentration (HP:0011016) | 1.81470558 |
| 185 | Prolonged neonatal jaundice (HP:0006579) | 1.79755534 |
| 186 | Arthralgia (HP:0002829) | 1.79710653 |
| 187 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79623711 |
| 188 | Neuronal loss in central nervous system (HP:0002529) | 1.78798658 |
| 189 | Abnormality of the pericardium (HP:0001697) | 1.77947283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.16639479 |
| 2 | ERN1 | 4.05972937 |
| 3 | SIK1 | 3.30863077 |
| 4 | FGFR4 | 3.05489779 |
| 5 | MST1R | 3.01821539 |
| 6 | RIPK4 | 2.80897722 |
| 7 | TAOK3 | 2.62522775 |
| 8 | INSRR | 2.55594743 |
| 9 | GRK7 | 2.54413924 |
| 10 | PDK3 | 2.48776843 |
| 11 | PDK4 | 2.48776843 |
| 12 | FRK | 2.41029779 |
| 13 | TAOK2 | 2.19547024 |
| 14 | TRIB3 | 2.14535869 |
| 15 | PRPF4B | 2.09698147 |
| 16 | MATK | 2.06539768 |
| 17 | PDK2 | 1.91016502 |
| 18 | DDR2 | 1.87909073 |
| 19 | PKN2 | 1.87581526 |
| 20 | PIK3CG | 1.75382541 |
| 21 | ERBB4 | 1.74966750 |
| 22 | TAOK1 | 1.72081118 |
| 23 | TXK | 1.71894856 |
| 24 | TYK2 | 1.71114025 |
| 25 | FGR | 1.68538862 |
| 26 | TBK1 | 1.67886054 |
| 27 | FLT3 | 1.67481555 |
| 28 | TGFBR2 | 1.54645506 |
| 29 | PTK6 | 1.54451689 |
| 30 | IRAK3 | 1.49044349 |
| 31 | NEK9 | 1.45665209 |
| 32 | PIK3CA | 1.42537201 |
| 33 | MAP3K13 | 1.42255857 |
| 34 | MAP3K3 | 1.42025066 |
| 35 | MOS | 1.40889513 |
| 36 | BMPR2 | 1.39808522 |
| 37 | PIM2 | 1.39304525 |
| 38 | MAP2K3 | 1.38960114 |
| 39 | MAP3K14 | 1.38154762 |
| 40 | TESK2 | 1.37611513 |
| 41 | MAPK11 | 1.27394421 |
| 42 | EPHB1 | 1.25000037 |
| 43 | KDR | 1.24141596 |
| 44 | CDC42BPA | 1.23962053 |
| 45 | SYK | 1.17351730 |
| 46 | ACVR1B | 1.17162161 |
| 47 | CAMK1D | 1.16935406 |
| 48 | ABL2 | 1.16551184 |
| 49 | JAK1 | 1.15539799 |
| 50 | TESK1 | 1.14931686 |
| 51 | CSK | 1.10310258 |
| 52 | LYN | 1.09339486 |
| 53 | JAK2 | 1.07759261 |
| 54 | MET | 1.07284573 |
| 55 | PRKAA2 | 1.07253105 |
| 56 | TIE1 | 1.06645242 |
| 57 | MYLK | 1.06164140 |
| 58 | LATS1 | 1.05933071 |
| 59 | RIPK1 | 1.02812093 |
| 60 | FES | 0.99742585 |
| 61 | PRKG2 | 0.97640423 |
| 62 | SIK3 | 0.95241193 |
| 63 | HCK | 0.89819818 |
| 64 | MAP2K2 | 0.88037794 |
| 65 | LCK | 0.87261934 |
| 66 | ADRBK2 | 0.84711068 |
| 67 | MAP2K4 | 0.84110190 |
| 68 | LMTK2 | 0.83575686 |
| 69 | STK10 | 0.83340392 |
| 70 | CHUK | 0.83014820 |
| 71 | PDPK1 | 0.78427793 |
| 72 | PBK | 0.76386537 |
| 73 | MAPK15 | 0.75850419 |
| 74 | IKBKE | 0.75199540 |
| 75 | ARAF | 0.74990185 |
| 76 | PINK1 | 0.71174303 |
| 77 | MAP3K7 | 0.70734662 |
| 78 | BLK | 0.69582011 |
| 79 | DYRK1B | 0.69096788 |
| 80 | PDK1 | 0.69070689 |
| 81 | WNK4 | 0.68533604 |
| 82 | MAP3K10 | 0.68473792 |
| 83 | CAMKK2 | 0.65414944 |
| 84 | MAP3K2 | 0.64650452 |
| 85 | PAK4 | 0.64192960 |
| 86 | CSF1R | 0.64112297 |
| 87 | ZAP70 | 0.63869159 |
| 88 | IRAK2 | 0.63735399 |
| 89 | PTK2 | 0.63206122 |
| 90 | STK38L | 0.63170048 |
| 91 | PRKAA1 | 0.62827073 |
| 92 | GRK6 | 0.62336979 |
| 93 | MAPK4 | 0.62206015 |
| 94 | MARK3 | 0.61969059 |
| 95 | GSK3A | 0.61066165 |
| 96 | MAP2K1 | 0.60450556 |
| 97 | EPHA3 | 0.60165508 |
| 98 | MAP2K6 | 0.60091944 |
| 99 | TTN | 0.59655880 |
| 100 | MAP3K12 | 0.59173157 |
| 101 | PRKACG | 0.58621059 |
| 102 | MAP3K11 | 0.58318129 |
| 103 | CAMK1G | 0.56121122 |
| 104 | ICK | 0.55167943 |
| 105 | CDK6 | 0.54110638 |
| 106 | MAP3K1 | 0.54082203 |
| 107 | ERBB2 | 0.53754937 |
| 108 | TNK2 | 0.52844728 |
| 109 | STK24 | 0.51038210 |
| 110 | KIT | 0.49196096 |
| 111 | PRKCZ | 0.48498886 |
| 112 | BMX | 0.47860198 |
| 113 | MAPK12 | 0.46935660 |
| 114 | IGF1R | 0.46770654 |
| 115 | FGFR3 | 0.45285895 |
| 116 | IRAK4 | 0.44893364 |
| 117 | IRAK1 | 0.41939784 |
| 118 | PIM1 | 0.41857351 |
| 119 | MAP4K1 | 0.41486513 |
| 120 | FGFR2 | 0.41094862 |
| 121 | GRK1 | 0.40839462 |
| 122 | JAK3 | 0.40817455 |
| 123 | CAMK2G | 0.40236174 |
| 124 | BTK | 0.40028644 |
| 125 | PRKCQ | 0.39612257 |
| 126 | IKBKB | 0.39307485 |
| 127 | LIMK1 | 0.38802785 |
| 128 | MAPKAPK2 | 0.38710576 |
| 129 | PDGFRA | 0.38623614 |
| 130 | TRPM7 | 0.37550732 |
| 131 | PTK2B | 0.37436450 |
| 132 | KSR2 | 0.37424317 |
| 133 | MAP3K5 | 0.37224156 |
| 134 | MAP3K6 | 0.37074002 |
| 135 | TEC | 0.37038226 |
| 136 | STK3 | 0.36858357 |
| 137 | NME2 | 0.36352150 |
| 138 | ABL1 | 0.36059489 |
| 139 | CLK1 | 0.36028928 |
| 140 | ITK | 0.35837241 |
| 141 | DAPK2 | 0.35717235 |
| 142 | MAPK7 | 0.34990892 |
| 143 | HIPK2 | 0.34805864 |
| 144 | LRRK2 | 0.34722488 |
| 145 | FYN | 0.34605198 |
| 146 | PDGFRB | 0.31620676 |
| 147 | RPS6KL1 | 0.31499430 |
| 148 | RPS6KC1 | 0.31499430 |
| 149 | EPHA2 | 0.31466828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93823520 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31039547 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.19308481 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.81576048 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73298146 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69003809 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66105019 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65521422 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62520171 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.58282871 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57000687 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55906644 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46884977 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43604450 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43039419 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42958763 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.39960516 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.35805619 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35524841 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23884962 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22709627 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19068481 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18530214 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18281907 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15222698 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11001935 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 2.07772184 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05090391 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 2.03349956 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02118732 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01593266 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01557373 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00612011 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98197648 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96665667 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93552656 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.93399076 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87760133 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80103823 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76993291 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71786004 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63725284 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.63125344 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62515103 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62263605 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62086193 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.61870728 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57692476 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55243453 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54220556 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53874255 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.51299592 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49999644 |
| 54 | * Sulfur metabolism_Homo sapiens_hsa00920 | 1.49233115 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47141854 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46426033 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43809590 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42498301 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 1.42250106 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39529863 |
| 61 | Measles_Homo sapiens_hsa05162 | 1.37437955 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36001528 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35383072 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34912098 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32975568 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31942309 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28908596 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27896820 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 1.25604519 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25317072 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22923622 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22554118 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22384080 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21361765 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18851254 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17203519 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16635010 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 1.15253803 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13511141 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09814301 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05058066 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04003212 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02882985 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01561905 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99896738 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99180319 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98699703 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95722394 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95429719 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95163971 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.92755109 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91263464 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88270144 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88267326 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87789649 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86702899 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.86407854 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84347116 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84108838 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83061825 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78385286 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77144130 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74216745 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74191669 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73476186 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73273736 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72255182 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72029694 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.71543266 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67428963 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64886672 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.64703423 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62113015 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55273873 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54907103 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51025808 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49834605 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48617183 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48605832 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48448776 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48370764 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45971662 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45809553 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45238580 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44926895 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.43592919 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40008961 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.39272067 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38437554 |
| 130 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37216656 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.34777367 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33333138 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33120280 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32837825 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31805502 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31611447 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30724742 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30718505 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28763873 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.27637727 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26252811 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24297588 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23892100 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20602045 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.19240446 |
| 146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18502113 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16363891 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15080034 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13114592 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10832825 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09344967 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.08939170 |
| 153 | Legionellosis_Homo sapiens_hsa05134 | 0.08588091 |
| 154 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08414842 |
| 155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07759036 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06479302 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.05624351 |
| 158 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04802606 |
| 159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00431868 |
| 160 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1034573 |
| 161 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1029242 |
| 162 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0944104 |
| 163 | Amoebiasis_Homo sapiens_hsa05146 | -0.0750828 |
| 164 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0567182 |
| 165 | Hepatitis C_Homo sapiens_hsa05160 | -0.0534488 |
| 166 | Malaria_Homo sapiens_hsa05144 | -0.0493354 |
| 167 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0476745 |
| 168 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0426132 |
| 169 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0068565 |
| 170 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0021130 |

